Search alternatives:
nm decrease » nn decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
nm decrease » nn decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
-
1
-
2
-
3
Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades
Published 2022“…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. …”
-
4
Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades
Published 2022“…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. …”
-
5
-
6
-
7
-
8
-
9
-
10
Discovery of Triazolyl Derivatives of Cucurbitacin B Targeting IGF2BP1 against Non-Small Cell Lung Cancer
Published 2023“…Derivative <b>A11</b> directly binds to the insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) protein with a <i>K</i><sub>D</sub> value of 2.88 nM, which is about 23-fold more potent than CuB, leading to the decreased expression of downstream apoptosis- and cell cycle-related proteins. …”
-
11
Preclinical Evaluation of <sup>131</sup>I/<sup>18</sup>F‑Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging
Published 2024“…This ratio significantly decreased in the blocking group (1.10 ± 0.14, **<i>P</i> < 0.01, <i>n</i> = 3). …”
-
12
Preclinical Evaluation of <sup>131</sup>I/<sup>18</sup>F‑Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging
Published 2024“…This ratio significantly decreased in the blocking group (1.10 ± 0.14, **<i>P</i> < 0.01, <i>n</i> = 3). …”
-
13
-
14
-
15
-
16
-
17
-
18
-
19
Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3‑Oxo-3,4-dihydro‑2<i>H</i>‑ben...
Published 2021“…Optimization of the left hand side afforded <b>4f</b> as a promising reversible MAGL inhibitor, which showed potent in vitro MAGL inhibitory activity (IC<sub>50</sub> 6.2 nM), good oral absorption, blood–brain barrier penetration, and significant pharmacodynamic changes (2-arachidonoylglycerol increase and arachidonic acid decrease) at 0.3–10 mg/kg, po. in mice.…”
-
20